Back
Eton Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
61
ETON
Eton Pharmaceuticals
Last Price:
8.66
Seasonality Move:
9.82%
Buy
57
BMRN
Biomarin Pharmaceutical
Last Price:
66.93
Seasonality Move:
13.3%
Buy
61
Eton Pharmaceuticals (ETON)
is a Buy
Is Eton Pharmaceuticals a Buy, Sell or Hold?
- The current Eton Pharmaceuticals [ETON] share price is $8.67. The Score for ETON is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- ETON is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.14. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ETON Stock Price Chart
What is Eton Pharmaceuticals's stock price today?
-
The Eton Pharmaceuticals share price today is $8.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ETON is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
ETON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 68.71 | Buy |
| Chaikin Money Flow: | -61501 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.38 - 8.68) | Buy |
| Bollinger Bands (100): | (3.24 - 6.98) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.96 | Sell |
| Relative Strength Index (14 RSI): | 30.39 | Sell |
| Chaikin Money Flow: | -992643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.33 - 70.61) | Sell |
| Bollinger Bands (100): | (71.38 - 88.36) | Sell |
ETON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.52 | Buy |
| 20-day SMA: | 8.31 | Buy |
| 50-day SMA: | 6.61 | Buy |
| 200-day SMA: | 4.5 | Buy |
| 8-day EMA: | 8.48 | Buy |
| 20-day EMA: | 8.08 | Buy |
| 50-day EMA: | 6.91 | Buy |
| 200-day EMA: | 4.97 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.17 | Sell |
| 20-day SMA: | 68.97 | Sell |
| 50-day SMA: | 74.08 | Sell |
| 200-day SMA: | 82.58 | Sell |
| 8-day EMA: | 67.03 | Sell |
| 20-day EMA: | 68.71 | Sell |
| 50-day EMA: | 72.98 | Sell |
| 200-day EMA: | 81.27 | Sell |
Eton Pharmaceuticals Earnings Growth & ETON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.71 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Eton Pharmaceuticals Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||